Elsevier

The Lancet

Volume 346, Issue 8986, 18 November 1995, Pages 1335-1337
The Lancet

Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection

https://doi.org/10.1016/S0140-6736(95)92346-2Get rights and content

Abstract

The role of intrauterine transfusion for fetal hydrops arising from maternal paravirus B19 infection is unclear. 66 cases of fetal hydrops arising from B19 infection were reported in England and Wales between June, 1992, and September, 1994. In 29 cases the fetus was dead at the time of the first abnormal ultrasound or a therapeutic abortion as performed; 12 of the 38 alive at the first abnormal scan received intrauterine transfusions and 3 of the 12 died. 26 did not receive intrauterine transfusions and 13 died. After adjustment for the severity of the hydrops as assessed by the ultrasound and for gestational age, the odds of death among those who received an intrauterine transfusion was significantly less than among those who did not (odds ratio 0·14, 95% Cl 0·02-0·96). These findings suggest that intrauterine transfusion will benefit some fetuses with hydrops arising from parvovirus B19 infection.

References (11)

  • SM. Hall

    Parvovirus B19 and pregnancy

    Rev Med Microbiol

    (1990)
  • Kp Gloning et al.

    Successful intrauterine treatment of fetal hydrops caused by parvovirus B19 infection

    Behring Inst Mitteilung

    (1990)
  • Mt Peters et al.

    Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection

    Obstet Gynecol

    (1990)
  • Tj Torok et al.

    Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique

    Clin Infect Dis

    (1992)
  • Md Kilby et al.

    Fetal anaemia

    Obstet Gynaecol Rev

    (1995)
There are more references available in the full text version of this article.

Cited by (149)

  • Parvovirus B19: a Clinical and Diagnostic Review

    2022, Clinical Microbiology Newsletter
    Citation Excerpt :

    In cases of severe chronic red cell aphasia, intravenous immune globulin therapy is effective, though it may cause rash or arthropathy [14]. Finally, intrauterine fetal blood transfusions have been utilized to mitigate B19V-induced hydrops fetalis [76]. Prevention of B19V exposure is challenging, as most individuals with B19V are asymptomatic and those that develop symptoms are infectious before clinical manifestation of disease.

  • Parvovirus b19 infection in pregnancy – A review

    2021, European Journal of Obstetrics and Gynecology and Reproductive Biology
  • Fetal Infections

    2019, Fetal Medicine: Basic Science and Clinical Practice
  • Parvovirus B19 Infection During Pregnancy

    2018, Obstetric Imaging: Fetal Diagnosis and Care: Second Edition
  • Prenatal diagnosis and management of fetal parvovirus B19 infection

    2017, Clinica e Investigacion en Ginecologia y Obstetricia
View all citing articles on Scopus
View full text